dementia

Reyes, C., Newby, D., Raventós, B., Verhamme, K., Mosseveld, M., Prieto-Alhambra, D., et al. (2024). Trends of use and characterisation of anti-dementia drugs users: a large multinational-network population-based study. Age Ageing, 53. http://doi.org/10.1093/ageing/afae106
View
Cordeiro, M. F., Denis, P., Astarita, C., Belsey, J., Rivas, M., & García-Feijoo, J. (2024). Prevalence of comorbidities with the potential to increase the risk of nonadherence to topical ocular hypotensive medication in patients with open-angle glaucoma. Curr Med Res Opin, 1-24. http://doi.org/10.1080/03007995.2024.2322048
View
Doran, W., Tunnicliffe, L., Muzambi, R., Rentsch, C. T., Bhaskaran, K., Smeeth, L., et al. (2024). Incident dementia risk among patients with type 2 diabetes receiving metformin versus alternative oral glucose-lowering therapy: an observational cohort study using UK primary healthcare records. Bmj Open Diabetes Res Care, 12. http://doi.org/10.1136/bmjdrc-2023-003548
View
Leahy, T. P., Simpson, A., Sammon, C., Ballard, C., & Gsteiger, S. (2023). Estimating the prevalence of diagnosed Alzheimer disease in England across deprivation groups using electronic health records: a clinical practice research datalink study. Bmj Open, 13, e075800. http://doi.org/10.1136/bmjopen-2023-075800
View
Lophatananon, A., Carr, M., McMillan, B., Dobson, C., Itzhaki, R., Parisi, R., et al. (2023). The association of herpes zoster and influenza vaccinations with the risk of developing dementia: a population-based cohort study within the UK Clinical Practice Research Datalink. Bmc Public Health, 23, 1903. http://doi.org/10.1186/s12889-023-16768-4
View
Zheng, B., Su, B., Ahmadi-Abhari, S., Kapogiannis, D., Tzoulaki, I., Riboli, E., & Middleton, L. (2023). Dementia risk in patients with type 2 diabetes: Comparing metformin with no pharmacological treatment. Alzheimers Dement. http://doi.org/10.1002/alz.13349
View
Lai, H. T. M., Chang, K., Sharabiani, M. T. A., Valabhji, J., Gregg, E. W., Middleton, L., et al. (2023). Twenty-year trajectories of cardio-metabolic factors among people with type 2 diabetes by dementia status in England: a retrospective cohort study. Eur J Epidemiol. http://doi.org/10.1007/s10654-023-00977-7
View
Rahman, A., Michaud, J., Dell'Aniello, S., Moodie, E. E. M., Brophy, J. M., Durand, M., et al. (2022). Oral Anticoagulants and the Risk of Dementia in Patients With Nonvalvular Atrial Fibrillation: A Population-Based Cohort Study. Neurology. http://doi.org/10.1212/wnl.0000000000206748
View
Watson, J., Green, M. A., Giebel, C., Darlington-Pollock, F., & Akpan, A. (2022). Social and spatial inequalities in healthcare use among people living with dementia in England (2002-2016). Aging Ment Health, 1-12. http://doi.org/10.1080/13607863.2022.2107176
View
Leniz, J., Gulliford, M., Higginson, I. J., Bajwah, S., Yi, D., Gao, W., & Sleeman, K. E. (2022). Primary care contacts, continuity, identification of palliative care needs, and hospital use: a population-based cohort study in people dying with dementia. Br J Gen Pract. http://doi.org/10.3399/bjgp.2021.0715
View